Dr Qian Zhang – Autoantibodies against type I IFNs in patients with life-threatening COVID-19 pneumonia

Event type: 
Seminar
Event date: 
Tuesday, 28 September 2021 - 1:00pm to 2:00pm
Cost: 
Free
Location: 

Webinar via Zoom
Please click on the link just before the start of the webinar

Contact for inquiries: 
Rata Joseph, +61 (2) 9385 0900 or info@kirby.unsw.edu.au
Booking deadline: 

 

Kirby Institute Seminar Series presents

Dr Qian Zhang  

Dr Qian Zhang
Research Associate, Rockefeller University, USA

Qian Zhang is a pediatrician who leads the influenza/COVID pneumonia team in the Casanova lab at Rockefeller University, USA.

Twitter: Qian Zhang @tutu_ZQ, Casanova Lab @casanova_lab
COVID Human Genetic Effort website: www.covidhge.com

 

Abstract

Auto-Abs neutralising type I IFNs predate SARS-CoV-2 infection and sharply increase in prevalence after the age of 70 years. They account for about 20% of both critical COVID-19 cases in the over-80s, and total fatal COVID-19 cases.

Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.

Location

Events